Hereditary disorders of the glomerular basement membrane

Pediatric Nephrology

Volumn 10, Issue 6, 1996, Pages 779-788

  Smeets, H J M ^a   Knoers, V V A M ^b   Van de Heuvel, L P W J ^b   Lemmink, H H ^b   Schroder C H ^b   Monnens, L A H ^b,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Glomerular basement membrane; Hereditary disorders

Indexed keywords

ALPORT SYNDROME; CHROMOSOME 19; CHROMOSOME 9Q; CONGENITAL NEPHROTIC SYNDROME; DENYS DRASH SYNDROME; GENE MUTATION; GENETIC DISORDER; GLOMERULUS BASEMENT MEMBRANE; HEMATURIA; HUMAN; NAIL PATELLA SYNDROME; NEPHROTIC SYNDROME; PRIORITY JOURNAL; REVIEW; X CHROMOSOME;

BASEMENT MEMBRANE; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; KIDNEY DISEASES; KIDNEY GLOMERULUS;

EID: 0029843416     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004670050217     Document Type: Review

References (101)

1. Gubler MC, Antignac C, Knebelmann (1994) Inherited glomerular disease. In: Pediatric nephrology. Holiday MA, Barratt TM, Avner ED (eds) Williams and Wilkins, Baltimore, pp 515-536
2. Ekblom P, Klein G, Ekblom M, Sorokin L (1991) Laminin isoforms and their receptor in the developing kidney. Am J Kidney Dis 17: 603-605
3. Jeraj K, Fish AJ, Yoshioka K, Michael AF (1984) Development and heterogeneity of antigens in the immature nephron. Am J Pathol 117: 180-183
4. Anand SK, Landing BH, Heuser ET, Olson DL, Grushkin CM, Lieberman E (1978) Changes in glomerular basement membrane antigens with age. J Pediatr 92: 952-953
5. Morita M, White RHR, Raafat F, Barnes JM, Standring DM (1988) Glomerular basement membrane thickness in children. Pediatr Nephrol 2: 190-195
6. Langeveld JPM, Veerkamp JH, Duyf CHP, Monnens L (1981) Chemical characterization of glomerular and tubular basement membranes of men of different ages. Kidney Int 20: 104-114
7. Mourner F, Foidart JM, Gubler MC (1986) Distribution of extra cellular matrix glycoproteins during normal development of human kidney. An immunohistochemical study. Lab Invest 54: 394-401
8. Kleppel MM, Michael AF (1990) Expression of novel basement membrane components in the developing human kidney and eye. Am J Anat 187: 165-174
9. 5 chains in rodent basal laminae: sequence, distribution, association with laminins and developmental switches. J Cell Biol 127: 879-891
10. Virtanen I, Laitinen L, Korhonen M (1995) Differential expression of laminin polypeptides in developing and adult human kidney. J Histochem Cytochem 43: 621-628
11. 1 Nature Genet 10:400-405
12. Couchman JR, Abrahamson DL, McCarthy KJ (1993) Basement membrane proteoglycan and development. Kidney Int 43: 79-84
13. Reubsaet FAG, Veerkamp JH, Monnens L (1985) Sulfated glycosaminoglycan content of glomerular and tubular basement membrane of individuals of different ages. Nephron 41: 344-347
14. Alport AC (1927) Hereditary familial congenital haemorrhagic nephritis. B M J 1: 504-506
15. Flinter FA, Cameron JS, Chantler C, Houston I, Bobrow M (1988) Genetics of classic Alport syndrome. Lancet II: 1005-1007
16. Atkin CL, Hasstedt SJ, Menlove L, Cannon L, Kirschner N, Schwartz C, Hguyen K, Skolnick MH (1988) Mapping of Alport syndrome to the long arm of the X chromosome. Am J Hum Genet 42: 249-255
17. Cochat P, Guibaud P, Torres R, Roussel B, Guarner V, Larbre F (1988) Diffuse letomyomatosis in Alport syndrome. J Pediatr 113: 339-343
18. Epstein CJ, Sahud MA, Piel CF, Goodman JR, Bernafield MR, Kushner JH, Ablin AR (1972) Hereditary macrothrombocytopenia, nephritis and deafness. Am J Med 52: 299-310
19. Kashtan CE, Butkowski RJ, Kleppel MM, Roy First M, Michael AF (1990) Posttransplant anti-glomerular basement membrane nephritis in related males with Alport syndrome. J Lab Clin Med 116: 508-515
20. Brunner HG, Schröder CH, Bennekom C van, Lambermon E, Tuerlings J, Menzel D, Olbing H, Monnens LAH, Wieringa B, Ropers HH (1988) Localization of the gene for X-linked Alport's syndrome. Kidney Int 34: 507-510
21. Flinter FA, Abbs S, Bobrow M (1989) Localization of the gene for classic Alport syndrome. Genomics 4: 335-338
22. Kashtan CE, Michael AF (1993) Alport syndrome: from bedside to genome to bedside. Am J Kidney Dis 22: 627-640
23. Kim KH, Kim Y, Gubler MC, Steffes MW, Lane PH, Kashtan CE, Crosson JT, Mauer SM (1995) Structural-functional relationships in Alport syndrome. J Am Soc Nephrol 5: 1659-1668
24. Kleppel MM, Kashtan CE, Butkowski RJ, Fish AJ, Michael AF (1987) Alport familial nephritis: absence of 28 kilodalton non-collagenous monomers of type IV collagen in glomerular basement membrane. J Clin Invest 80: 263-266
25. Thorner P, Baumal R, Eddy A, Marrano PM (1990) A study by immunofluorescence of the NC1 domain of collagen type IV in glomerular basement membranes of two patients with hereditary nephritis. Virchows Archiv [A] 416: 205-212
26. Kleppel MM, Kashtan C, Santi PA, Wieslandcr J, Michael AF (1989) Distribution of familial nephritis antigen in normal tissue and renal basement membranes of patients with homozygous and heterozygous Alport familial nephritis. Lab Invest 61: 278-289
27. Savage COS, Noel LH, Crutcher E, Price SRG, Grunfeld JP, Lockwood CM (1989) Hereditary nephritis: immunoblotting studies of the glomerular basement membrane. Lab Invest 60: 613-618
28. Van den Heuvel LPWJ, Schröder CH, Savage COS, Menzel D, Assmann KJM, Monnens LAH, Veerkamp JH (1989) The development of anti-glomerular basement membrane nephritis in two children with Alport's syndrome: characterization of the antibody target. Pediatr Nephrol 3: 406-413
29. Pihlajaniemi T, Tryggvason K, Myers J, Kurkinen M, Lebo R, Cheung M, Prockop DJ, Boyd CD (1985) cDNA clones coding for the pro-α1(IV) chain of human type IV procollagen revealed an unusual homology of amino acid sequences in two halves of the carboxyterminal domain. J Biol Chem 260: 7681-7687
30. Hostikka SL, Eddy RL, Byers MG, Höyhtya M, Shows TB, Tryggvason K (1990) Identification of a distinct type IV collagen a chain with restricted kidney distribution and assignment to the locus of X chromosome linked Alport syndrome. Proc Natl Acad Sci USA 87: 1606-1610
31. Leinonen A, Mariyama M, Mochizuki T, Tryggvason K, Reeders ST (1994) Complete primary structure of the human type IV collagen α4(IV) chain. J Biol Chem 269: 26172-26177
32. Mariyama M, Leinonen A, Mochizuki T, Tryggvason K, Reeders ST (1994) Complete primary structure of the human α3(IV) collagen chain. Coexpression of the α3(IV) and α4(IV) collagen chain in human tissues. J Biol Chem 269: 23013-23017
33. Myers JC, Jones TA, Pohjalainen ER, Kadri AS, Goddard AD, Sheer D, Solomon E, Pihlajaniemi T (1990) Molecular cloning of α5(IV) collagen and assignment of the gene to the region of the X-chromosome containing the Alport syndrome locus. Am J Hum Genet 46: 1024-1033
34. Barker D, Hostikka SL, Zhou J, Chow T, Oliphant AR, Gerken SC, Gregory MCV, Skolnick MH, Atkin CL, Tryggvason K (1990) Identification of mutations in the COL4A5 collagen gene in Alport syndrome. Science 248: 1224-1227
35. Flinter F (1994) 3rd International workshop on Alport syndrome. Conference report. Pediatr Nephrol 8: 780-782
36. Zhou J, Mochizuki T, Smeets H, Antignac C, Laurila P, Paepe A de, Tryggvason K, Reeders ST (1993) Deletion of the paired α5(IV) and α6(IV) collagen genes in inherited smooth muscle tumors. Science 261: 1167-1169
37. Oohashi T, Sugimoto M, Mattel M-G, Ninomiya Y (1994) Identification of a new collagen IV chain, α6(IV) by cDNA isolation and assignment of the gene to chromosome Xq22, which is the same locus for COL4A5. J Biol Chem 269: 7520-7526
38. Mochizuki T, Lemmink HH, Mariyama M, Antignac C, Gubler M-C, Pirson Y, Verellen-Dumoulin C, Schröder CH, Smeets HJM, Reeders ST (1994) Identification of mutations in the α3(TV) and 1d4(IV) collagen genes in autosomal recessive Alport syndrome. Nature Genet 8: 77-82
39. Lemmink HH, Mochizuki T, Van den Heuvel LPWJ, Schröder CH, Barrientos A, Monnens LAH, Van Oost BA, Brunner HG, Reeders ST, Smeets HIM (1994) Mutations in the type IV α3 (COL4A3) gene in autosomal recessive Alport syndrome. Hum Mol Genet 3: 1269-1273
40. Heidet L, Dahan K, Zhou J, Xu Z, Cochat P, Gould JDM, Leppig KA, Proesmans W, Guyot C, Roussel B, Tryggvason K, Grünfeld JP, Gubler MC, Antignac C (1995) Deletions of both α5(IV) and α6(IV) collagen genes in Alport syndrome and in Alport syndrome associated with smooth muscle tumours. Hum Mol Genet 4: 99-108
41. Knebelmann B, Forestier L, Drouot L, Quinones S, Chuet C, Benessy F, Saus J, Antignac C (1995) Splice-mediated insertion of an Alu sequence in the COL4A3 mRNA causing autosomal recessive Alport syndrome. Hum Mol Genet 4: 675-679
42. Milliner DS, Pieredes AN, Holley KE (1982) Renal transplantation in Alport's syndrome: anti-glomerular basement membrane glomerulonephritis in the allograft. Mayo Clin Proc 57: 35-43
43. Gubler MC, Antignac C, Deschenes G, Knebelmann B, Hors-Cayla MC, Grünfeld JP, Broyer M, Habib R (1993) Genetic, clinical and morphologic heterogeneity in Alport syndrome. Adv Nephrol 22: 15-35
44. Kalluri R, Weber M, Netzer KO, Sun MJ, Neilson EG, Hudson BG (1994) COL4A5 gene deletion and production of post-transplant anti-α3(IV) collagen alloantibodies in Alport syndrome. Kidney Int 47: 1199-1204
45. Van den Heuvel LPWJ, Schröder CH, Savage COS, Assmann KJM, Monnens LAH, Veerkamp JH (1989) The development of anti-glomerular basement membrane nephritis in two children with Alport's syndrome after renal transplantation: characterization of the antibody target. Pediatr Nephrol 3: 406-413
46. Reeders ST (1992) Molecular genetics of hereditary nephritis. Kidney Int 42: 783-792
47. Kleppel MM, Fan WW, Cheong HT, Michael AF (1992) Evidence for separate networks of classical and novel basement membrane collagen. Characterization of α3(IV)-Alport antigen heterodimer. J Biol Chem 267: 4137-4142
48. Kashtan CE, Kim Y (1992) Distribution of the α1 and α2 chains of collagen IV and of collagens V and VI in Alport syndrome. Kidney Int 42: 115-126
49. Gubler MC, Knebelman B, Beziau A, Broyer M, Pirson Y, Haddoum F, Kleppel MM, Antignac C (1995) Autosomal recessive Alport syndrome: immunohistochemical study of type IV collagen chain distribution. Kidney Int 47: 1142-1147
50. Nakanishi K, Yoshikawa N, Lijima K, Kitagawa K, Nakamura H, Ito H, Yoshioka K, Kagawa M, Sado Y (1995) Immunohistochemical study of the α1 - 5 chains of type IV collagen in hereditary nephritis. Kidney Int 46: 1413-1421
51. Yoshioka K, Hino S, Takemura T, Maki S, Wieslander J, Takekoshi Y, Makino H, Kagawa M, Sado Y, Kashtan CE (1994) Type IV collagen α5 chain; normal distribution and abnormalities in X-linked Alport syndrome revealed by monoclonal antibody. Am J Pathol 144: 986-996
52. Yamazaki H, Nakagawa Y, Saito A, Nishi S, Sakatsume M, Takeda T, Maruyama Y, Ogino S, Maruyama S, Mochizuki T, Reeders S, Arakawa M (1995) No linkage to the COL4A3 gene locus in Japanese thin basement membrane disease families. Nephrol 1: 315-321
53. Little EM (1897) Congenital absence or delayed development of the patella. Lancet II: 781-784
54. Mino RA, Mino VH, Livingstone RG (1948) Osseous dysplasia and dystrophy of the nail: review of literature and report of a case. Am Rontgenol 60: 633-641
55. Pieron R, Mafart Y, Couderc LJ, Roussin S (1982) Osteo-onychodysplasia. Un cas avec revue de la literature. Semin Hop Paris 58: 1039-1042
56. Raman D, Haslock I (1983) The nail-patella syndrome. A report of two cases and a literature review. Br J Rheumatol 22: 41-46
57. Meyrier A, Rizzo R, Gubler MC (1990) The nail-patella syndrome. A review. J Nephrol 2: 133-140
58. Lucas GL, Opitz JM, Wiffler C (1966) Nail-patella syndrome. J Pediatr 68: 273-287
59. Lester AM (1936] A familial dyschondroplasia associated with anonychia and other deformities. Lancet II: 1519
60. Hoyer JR, Michael AF, Vernier RL (1972) Renal disease in nail-patella syndrome: clinical and morphologic studies. Kidney Int 2: 231-238
61. Bennett WM, Musgrave JE, Campbell RA, Elliot D, Cox R, Brooks RE, Lovrien EW, Beals RK, Porter GA (1973) The nephropathy of the nail-patella syndrome. Am J Med 54: 304-319
62. Zollinger HU, Mihatsch MJ (1978) Renal pathology in biopsy. Springer, Berlin Heidelberg New York, pp 476-478
63. Ben Bassat M, Cohen L, Rosenfeld J (1971) The glomerular basement membrane in the nail-patella syndrome. Arch Pathol 92: 350-355
64. Taguchi T, Takebayashi S, Nishimura M, Tsuru N (1988) Nephropathy of nail-patella syndrome. Ultrastruct Pathol 12: 175-183
65. Sabnis SG, Antonovych TT, Argy WP, Rawowski TA, Candy DR, Salcedo JR (1980) Nail-patella syndrome Clin Nephrol 14: 148-153
66. Dombros N, Katz A (1982) Nail-patella-like lesions in the absence of skeletal abnormalities. Am J Kidney Dis 1: 237-240
67. Salcedo JR (1984) An autosomal recessive disorder with glomerular basement membrane abnormalities similar to those seen in the nail-patella syndrome. Report of a kindred. Am J Med Genet 19: 579-584
68. Renwick JH, Lawler SD (1955) Genetic linkage between the ABO and nail-patella loci. Ann Hum Genet 19: 312-331
69. Schleutermann DA, Bias WB, Murdoch JL, McKusick VA (1969) Linkage of the loci for the nail-patella syndrome and adenylate kinase. Am J Hum Genet 21: 606-630
70. Campeau E, Watkins D, Rouleau GA, Babul R, Buchanan JA, Meschino W, Der Kaloustian VM (1995) Linkage analysis of the nail-patella syndrome. Am J Hum Genet 56: 243-247
71. Greenspan DS, Byers MG, Eddy RL, Cheng W, Jani-Sait S, Shows TB (1992) Human collagen gene COL5A1 maps to the q34.2-q34.3 region of chromosome 9, near the locus for nail-patella syndrome. Genomics 12: 836-837
72. Caridi G, Ghiggeri M, Pezzolo A, Gimelli G, Gusmano R (1994) Co-localization of COL5A1 with the nail-patella Socus on the long arm of chromosome 9. Proceedings of the annual EDTA-ERA Congress, Vienna. Nephrol Dial Transplant 9: 949
73. Ghiggeri GM, Caridi G, Altieri P, Pezzolo A, Gimelli G, Zuffardi O (1993) Are the nail-patella syndrome and the autosomal Goltz-like syndrome the phenotypic expressions of different alleles at the COL5A1 locus? Hum Genet 91: 175-177
74. Greenspan DS, Papenberg KA, Northrup H, Wenstrup R, Marchuk DA, Kwiatkowski DJ (1994) COL5A1: fine genetic mapping, intron/exon organization and exclusion as candidate gene in families with tuberous sclerosis complex I, hereditary hemorrhagic teleangiectasia, and Ehlers Danlos syndrome type II. Am J Hum Genet 55 [Suppl]: A132
75. Uranga VM, Simmons RL, Hoyer JR, Kjellstrand CM, Buselmeier TJ, Najarian JS (1973) Renal transplantation for the nail-patella syndrome. Am J Surg 125: 777-779
76. Chan PCK, Chan KW, Cheng IKP, Chan MK (1988) Living-related renal transplantation in a patient with nail-patella syndrome. Nephron 50: 164-166
77. Mauch TJ, Vernier RL, Burke BA, Nevins TE (1994) Nephrotic syndrome in the first year of live. In: Holliday MA, Barratt TM, Avner ED (eds) Pediatric nephrology. Williams and Wilkins, Baltimore, pp 788-802
78. Habib R (1993) Nephrotic syndrome in the 1st year of life. Pediatr Nephrol 7: 347-353
79. Kestilä M, Männikkö M, Holmberg C, Gyapay G, Seissenbach J, Savolainen ER, Peltonen L, Tryggvason K (1994) Congenital nephrotic syndrome of the Finnish type maps to the long arm of chromosome 19. Am J Human Genet 54: 757-764
80. Kestilä M, Määniko M, Holmberg C, Korpela K, Savolainen ER, Peltonen L, Tryggvason K (1994) Exclusion of eight genes as mutated loci in congenital nephrotic syndrome of the Finnish type. Kidney Int 45: 986-990
81. Heuvel L van, Born J van de, Jalanko H, Schröder CH, Veerkamp JH, Assmann KJM, Berden JHM, Holmberg C, Rapola J, Monnens LAH (1992) The glycosaminoglycan content of renal basement membranes in congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 6: 10-15
82. Ljunberg P (1994) Glycosaminoglycans in urine and amniotic fluid in congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 8: 531-536
83. Laine J, Jalanko H, Holhöfer H, Krogerus L, Rapola J, Von Willebrand E, Lautenschlager I, Salmela K, Holmberg C (1993) Post-transplantation nephrosis in congenital nephrotic syndrome of the Finnish type. Kidney Int 44: 874-876
84. Holmberg C, Antikainen M, Rönnholm K, Ala-Howhala M, Jalanko H (1995) Management of congenital nephrotic syndrome of the Finnish type. Pediatr Nephrol 9: 87-93
85. Denys P, Malvaux P, Van den Berghe H, Tanghe W, Proesmans W (1967) Association d'un syndrome anatomopathologique de pseudohermaphroditism masculin, d'une tumeur de Wilms, d'une nephropathie parenchymateuse et d'un mosaicisme XX/XY. Arch Fr Pediatr 24: 729-739
86. Drash A, Sherman F, Hartmann WH, Blizzard RM (1970) A syndrome of pseudohermaphroditism, Wilm's tumor, hypertension, and degenerative renal disease. J Pediatr 76: 585-593
87. Pelletier J, Breuning W, Kashtan CE, Mauer M, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, Fine RN, Silverman BL, Haber DA, Housman D (1991) Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 67: 437-447
88. Müller RF (1994) The Denys-Drash syndrome. J Med Genet 31: 471-477
89. Rauscher FJ (1993) The WT1 Wilms tumor gene product: a developmentally regulated transcription factor in the kidney that functions as a tumor suppressor. FASEB J 7: 896-903
90. Kreidberg JA, Sariola H, Loring JM, Maeda M, Pelletier J, Housman D, Jaenisch R (1993) WT-1 is required for early kidney development. Cell 74: 679-691
91. Pritchard Jones K, Fleming S, Davidson D, Bickmore W, Porteous D, Gosden C, Bard J, Buckler A, Pelletier JJ, Housman D, Van Heiningen V, Hastie N (1990) The candidate Wilms' tumour gene is involved in genitourinary development. Nature 346: 194-197
92. Bruening W, Bardeesy N, Silverman BL, Cohn RA, Machin GA, Aronson AJ, Housman D, Pelletier J (1992) Germline intronic and exonic mutations in the Wilms tumour gene (WTI) affecting urogenital development. Nature Genet 1: 144-148
93. Coppes MJ, Liefers GJ, Higuchi M, Zinn AB, Balfe JW, Williams BRG (1993) Inherited WT1 mutation in Denys-Drash syndrome. Cancer Res 52: 6125-6128
94. Little MH, Williamson KA, Mannens M, Kelsey A, Gosden C, Hastie ND, Van Heiningen V (1993) Evidence that WT1 mutations in Denys-Drash syndrome patients may act in a dominant-negative fashion. Hum Mol Genet 2: 259-264
95. Coppes MJ, Liefers GJ, Higuchi M, Zinn AB, Balfe JW, Williams BRG (1993) Inherited WTI mutation in Denys-Drash syndrome. Cancer Res 52: 6125-6128
96. Little M, Holmes G, Bickmore W, Van Heijningen V, Hastie N, Wainwright B (1995) DNA binding capacity of the WT1 protein is abolished by Denys-Drash syndrome WT1 point mutations. Hum Mol Genet 4: 351-358
97. Abrahamson DR (1987) Structure and development of the glomerular capillary wall and basement membrane. Am J Physiol 253: 783-794
98. Van den Heuvel LPWJ, Westenend PJ, Van den Born J, Assmann KJM, Knoers N, Monnens LAH (1995) Aberrant proteoglycan composition of the glomerular basement membrane in a patient with Denys-Drash syndrome. Nephrol Dial Transplant 10: 2205-2211
99. Cohen AH, Turner MC (1994) Kidney in Galloway-Mowat syndrome: clinical spectrum with description of pathology. Kidney Int 45: 1407-1415
100. Sperl W, Gruber W, Quatacker J, Monnens L, Thoenes W, Fink F, Paschke E (1990) Nephrosis in two infants with infantile sialic acid storage disease. Eur J Paediatr 149: 477-482
101. Fuchshuber A, Jean G, Gribouval O, Gubler MC, Broyer M, Beckmann JS, Niaudet P, Anttgnac C (1995) Mapping a gene to chromosome 1q25-q31 in idiopathic nephrotic syndrome confirms a distinct entity of autosomal recessive nephrosis Hum Mol Genet 11: 2155-2158